Abstract
Recent technological advances in transgenic plants expressing recombinant proteins have resulted in the possibility of paradigm shifts in the area of animal healthcare (Hood et al., 1997). By expressing proteins in edible tissue, the possibility of delivering a healthcare product directly by ingestion of the edible tissue is now becoming a reality. In addition to the potential ease of application, the low cost of production and the enormous amounts of product that can be produced in a plant-based system offer the possibility of disease control on a large scale. The types of products possible to be delivered in this manner could include therapeutic proteins, growth promotants, vaccines, monoclonal antibodies and proteins with antimicrobial activity. To date most activity in this area has focused upon the development of plant-based vaccines.
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Ahtnad S, Lohman, B, Marthas M, Giavedoni L, el Amad, Z, Haigwood NL, Scandella CJ, Gardner MB, Luciw PA and Yilma T. 1994. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10: 195-204.
Arakawa T, Chong DK, Merritt JL and Langridge WH. 1997. Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. 6: 403–413.
Arakawa T, Yu J and Langridge WH. 1999. Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization. Adv. Exp. Med. Biol. 464: 161-178.
Bergmeier LA, Mitchell EA, Hall G, Cranage MP, Cook N, Dennis M and Lehner T. 1998. Antibody-secreting cells specific for simian immunodeficiency virus antigens in lymphoid and mucosal tissues of immunized macaques. AIDS 12: 1 139–1147.
Czerkinsky C, Svennerholm AM and Holmgren J. 1993. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16 Suppl2: S106–S116.
Daniell H, Lee SB, Panchal T and Wiebe PO. 2001. Expression of the native cholera toxin b subunit gene and assembly as functional oligomers in transgenic tobaccochloroplasts. J Mol Biol; 311 (5): 1001–1009
Garvey PB, Hammond J, Dienelt MM, Hooper DC. Fu DF, Dietzschold B, Koprowski Hand Michaels FH. 1995. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology (N. Y. ) 13: 1484-1487.
Gomez N, Carrillo C, Salinas J, Parra F, Borca MV and Escribano JM. 1998. Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenterities coronavirus in transgenic plants. Virology 249: 352–358.
Guidry JJ, Cardenas L, Cheng E and Clements JD. 1997. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Esche ricin coli heat-labile enterotoxin. Immunology 65: 4943–4950.
Hag, TA, Mason, HS, Clements J and Arntzen CJ. 1995. Production of an orally immunogenic bacterial protein in transgenic plants: proof of concept of edible vaccines. Science 268: 714–716.
Holmgren J, Czerkinsky C, Lycke N and Svennerholm AM. 1994. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am. J. Trop. Med. Hyg. 50: 42-54.
Hood, EE, Witcher DR, Maddock S, Meyer T, Baszczynski CBM, Flynn P, Register J, Marshal L, Bond D, Kulisek E, Kusnadi A, Evangelista R, Nikolov Z, Wooge C, Mehigh RJ, Hernan R, Kappel WK, Ritland, D, Li PC and Howard JA. 1997. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Molecular Breeding 3: 291–306.
Hood EE and Jilka JM. 1999 Plant-based production of xenogenic proteins. Cuff Opin Biotechnol. 4: 382–6
Ishida Y, Saito H, Ohta S, Hiei Y, Komari T and Kumashiro T. 1996. High efficiency transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens. Nat. Biotechnol. 14: 745-750.
Kapusta J, Modelska A, Figlerowicz M, Pniewski T, Letellier M, Lisowa O, Yusibov V, Koprowski H, Plucienniczak A and Legocki AB. 1999. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 13: 1796–1799.
Kusnadi, A., R. Evangelista, E. E. Hood, J. A. Howard, and Z. Nikolov. 1998. Processing of transgenic corn seed and its effect on the recovery of recombinant ß-glucuronidase. Biotechnol. Bioeng. 60: 44-52.
Kusnadi AR. 1998. Production and purification of two recombinant proteins from transgenic corn. Biotechnol. Prog. 14: 149–155.
Lauterslager TG, Florack DE, van der Wal TJ, Molthoff JW, Langeveld JP, Bosch D, Boersma WJ and Hilgers LA. 2001. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine 19: 2749–2755
Laude H, Rasschaert D, Delmas B, Godet M, Gelfi J and Charley B. 1990 Molecular biology of transmissible gastroenteritis virus. Vet Microbiol 23: 147–54.
Lee RW, Strommer J, Hodgins D, Shewen PE and Niu Y,LoRY. 2001 Towards Development of an Edible Vaccine against Bovine Pneumonic Pasteurellosis Using Transgenic White Clover Expressing a Mannheimia haemolytica Al Leukotoxin 50 Fusion Protein. Infect Immun 69 (9): 5786–5793.
Lu X, Kiyono H, Lu D, Kawabata S, Torten T, Srinivasan S, Dailey PJ, McGhee JR, Lehner T and CJ Miller. 1998. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SlVmac251. AIDS 12: 1–10.
Mason HS, Lam DM and Arntzen CJ. 1992 Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci USA;89:1 1 745-1 749.
Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK and Arntzen O. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. Natl. Acad. Sci. U. S. A 93: 5335-5340.
Mason HS, Haq TA, Clements JD and Arntzen CJ. 1998. Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine 16: 1336–1343.
Modelska A, Dietzschold B, Sleysh N, Fu ZF, Steplewski K, Hooper DC, Koprowski H and Yusibov V. 1998 Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA Mar 3;95(5): 2481–5.
Moldoveanu Z, Vzorov AN, Huang WQ, Mestecky J and Compans RW. 1999. Induction of immune responses to SIV antigens by mucosally administered vaccines [In Process Citation]. AIDS Res. Hum. Retroviruses 15: 1469-1476.
Pen J, Molendijk L, Quax WJ, Sijmons PC, van Doyen AJ, van den Elzen PJ, Rietveld K and Hoekema A. 1992. Production of active Bacillus licheniformis alpha-amylase in tobacco and its application in starch liquefaction. Biotechnology (N. Y. ) 10: 292-296.
Richter LJ, Thanavala Y, Arntzen CJ and Mason HS. 2000. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 18 (11): 1167–1171
Rued] C and Wolf H. 1995. Features of oral immunization. Int. Arch. Allergy Immunol. 108: 334–339.
Saif LJ and Wesley RD. 1992. Transmissible Gastroenteritis, Diseases of Swine 7th Edition, Iowa State University Press 29: 362–386.
Saif LJ, van Cott JL and Brim TA. 1994. Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine. Vet. Immunol. Immunopathol. 43: 89–97.
Sandhu JS, Krasnyanski SF, Domier LL, Korban SS. Osadjan MD and Buetow DE. 2000. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res 9(2):127-135.
Streatfield S.1, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, Woodard SL, Beifuss KK, Horn ME, Delaney DE, Tizard 1R and Howard JA. 2001. Plant-based vaccines: unique advantages. Vaccine(19): 2742–2748.
Svennerholm A-M and Holmgren J. 1995 Oral B-subunit whole-cell vaccines against cholera and enterotoxigenic Escherichia coli diarrhea. In: Ala'Aldeen DAA, Hormaeche CE, editors. Molecular and Clinical Aspects of Bacterial Vaccine Development. Chichester, England: Wiley, 205–32.
Sixma TK, Pronk SE and Kalk KH et al. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351: 371–377.
Tuboly T, Yu W, Bailey A, Degrandis S, Du S, Erickson L and Nagy E. 2000. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine (18): 2023–2028.
Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM and Arntzen CJ. 1998. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4: 607–9.
Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM and Arntzen CJ. 2000. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182: 302–5.
Thanavala Y, Yang Y-F, Lyons P, Mason HS and Arntzen CJ. 1995. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl. Acad. Sci. U. S. A 92: 3358-3361.
Trudel J, Potvin C and Asselin A. 1992. Expression of active hen egg white lysozyme in transgenic tobacco. Plant Sci. 87: 55–67.
Tuboly T, Yu W, Bailey A, Degrandis S, Lerickson S Du and Nagy E. 2000. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants. Vaccine 18: 2023–2028.
Wigdorovitz A, Carrillo C, Dus Santos MJ, Trono K, Peralta A, Gomez MC, Rios RD, Franzone PM, Sadir AM, Escribano JM and Borca MV. 1999. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255: 347–353.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Jilka, J.M., Streatfield, S.J. (2002). Animal Health. In: Hood, E.E., Howard, J.A. (eds) Plants as Factories for Protein Production. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2693-1_5
Download citation
DOI: https://doi.org/10.1007/978-94-017-2693-1_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6113-3
Online ISBN: 978-94-017-2693-1
eBook Packages: Springer Book Archive